http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0895783-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41a639aa11b9b2f8063a3e6b8b22b557
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
filingDate 1998-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_122e737adfc68c1cf454cfb4166ae894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e1ed2d8c671fdec384922be8b70f85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ddc5016f0356ff8fb2bc4e261c8df1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c9c245333698097f1df0e70a1cf252f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caa711e307fd1baa4a89d04dac8c74c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dfc3b630aeaf1ba143a6a2b0624f617
publicationDate 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0895783-B1
titleOfInvention Use of Carnitine for antagonising the tubular damage caused by Ifosfamide
abstract Use of ifosfamide and carnitine for treatment of tumours is new.
priorityDate 1997-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128916092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135835314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136314073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9588020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136033352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129926949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57317596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129112797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57150298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058880

Total number of triples: 54.